Postpartum depression, or depression in women within 12 months of giving birth, is common. It affects one-quarter of these women, which is why current recommendations are to begin screening for depression during pregnancy. Left un- and under-treated, the mother, newborn, and family are at risk for relationship problems, psychiatric illness, and other consequences. In this 1-hour, case-based activity, developed by family medicine and mental health clinicians, team-based screening recommendations, along with strategies for overcoming barriers in diagnosis, are applied to primary care practice. The risks and benefits of treatment, including nonpharmacologic and pharmacologic options, such as selective serotonin reuptake inhibitors and neuroactive steroid gamma-aminobutyric acid A receptor positive modulators, are discussed, to enable the development of a personalized care plan using a collaborative care model.

Presenting Faculty

• 

  Anita H. Clayton, MD

  Wilford W. Spradlin Professor and Chair
  Department of Psychiatry and Neurobehavioral Sciences
  Professor, Clinical Obstetrics and Gynecology
  University of Virginia School of Medicine
  Charlottesville, Virginia

• 

  Sarah Nagle-Yang, MD

  Vice Chair for Quality
  Deputy Executive Director, Colorado Center for Women's Behavioral Health
  Associate Professor of Psychiatry
  University of Colorado School of Medicine
  Aurora, Colorado

• 

  Barbara P. Yawn, MD

  Adjunct Professor
  University of Minnesota
  Department of Family and Community Health
  Minneapolis, Minnesota